Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.
about
Interventions for morpheaMedical Therapy of Fibrostenotic Crohn's DiseaseCorrelations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Pirfenidone gel in patients with localized scleroderma: a phase II study.Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.Treatment of systemic sclerosis: potential role for stem cell transplantation.Transforming growth factor-β1 in plaque morphea.Morphea associated with the use of adalimumab: a case report and review of the literature.The role of dendritic cells and regulatory T cells in the pathogenesis of morphea.UVA1 a promising approach for scleroderma.Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.Oxidative stress parameters in localized scleroderma patients.Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib.
P2860
Q24194241-ED511603-6505-4DD5-91E5-A41FE61D9B0AQ26777724-C2F3133F-A5D5-4629-82DA-65A524A0D632Q30825417-B0781118-9CEB-4AED-9189-12D5661B7735Q34504710-597546C5-E297-475D-962E-8BE4B2EB7447Q35025056-1ABE49D7-227E-41A5-887D-1FDD9D121515Q36051223-E976FCD9-E653-4A26-BE36-B957DE53EF4AQ37194001-7914C756-6ED4-462C-9838-91C4B4A7A41AQ37535719-8812503E-DBB8-4FBF-9F1F-65B5C5F83938Q37957758-273424B1-93B7-439A-A962-DB81546AF44CQ38544036-D0D7957A-3E13-448D-AF10-96E3DB629C16Q42367920-4EBDFAA4-62EE-4464-B600-EE4124258E0BQ47133681-04963F5C-63C3-4C42-A994-B32F7B57B532Q51534954-595BDF23-9391-4BAB-BBD3-9926521737C9Q55519143-A858457F-455C-4BFB-A80F-80AB6559D420
P2860
Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pathogenesis and therapeutic a ...... oderma and systemic sclerosis.
@en
Pathogenesis and therapeutic a ...... oderma and systemic sclerosis.
@nl
type
label
Pathogenesis and therapeutic a ...... oderma and systemic sclerosis.
@en
Pathogenesis and therapeutic a ...... oderma and systemic sclerosis.
@nl
prefLabel
Pathogenesis and therapeutic a ...... oderma and systemic sclerosis.
@en
Pathogenesis and therapeutic a ...... oderma and systemic sclerosis.
@nl
P2093
P356
P1433
P1476
Pathogenesis and therapeutic a ...... oderma and systemic sclerosis.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEN405
P577
2008-11-20T00:00:00Z